Journal
JOURNAL OF CLINICAL PHARMACOLOGY
Volume 47, Issue 1, Pages 101-111Publisher
WILEY
DOI: 10.1177/0091270006295789
Keywords
busulfan; pharmacokinetics; dosing; modeling; pediatrics
Categories
Ask authors/readers for more resources
The objective of this study was to characterize the pharmacokinetics (PK) of intravenous busulfan in pediatric patients and provide dosing recommendations. Twenty-four pediatric patients were treated with intravenous busulfan, 1.0 or 0.8 mg/kg for ages <= 4 years or > 4 years, respectively, 4 times a day for 4 days. Dense PK sampling was performed. Body weight, age, gender, and body surface area were explored for effects on PK, and Monte Carlo simulations were performed to assess different dosing regimens. The PK of intravenous busulfan was described by a 1-compartment model with clearance of 4.04 L/h/20 kg and volume of distribution of 12.8 L/20 kg. Simulations indicated that the mg/kg and mg/m(2) regimens were similar and achieved the desired target exposure in approximately 60% of patients. This model suggests that patients <= 12 kg should be dosed at 1.1 mg/kg and those > 12 kg dosed at 0.8 mg/kg. Therapeutic drug monitoring and dose adjustment will further improve therapeutic targeting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available